Mounjaro 15mg
$300.00
Mounjaro (tirzepatide) is a prescription medication approved for the management of type 2 diabetes. It acts as a dual GIP and GLP-1 receptor agonist, improving blood sugar control while often supporting weight loss. It is typically administered once weekly by subcutaneous injection.
Key Features:
FDA-approved treatment for type 2 diabetes
Dual action on GIP and GLP-1 receptors
May help with weight reduction in addition to glycemic control
Reviews
There are no reviews yet.